Form D Explorer
HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC · CIK 1978468

Report a data issueCitable research briefCompare issuerPrivate research collection

HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC

CIK 1978468 · Limited Liability Company · Inc. DELAWARE · CARY, North Carolina · Pooled Investment Fund

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Oct 20, 2025
through Dec 15, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 20, 2025 · DDec 15, 2025 · D/ALater minus earlier
Reported offering amount$1,000,000$1,000,000$0
Reported amount sold$0$204,000$204,000
Reported investor count———
Reported minimum investment$5,000$5,000$0

Earlier SEC source: 0001978468-25-000002 · Later SEC source: 0001978468-25-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Dec 15, 2025

Reported offering amount
$1,000,000
Reported exemptions
Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1)
Reported amount sold
$204,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Same parent named in series designation

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)